Medical journal retracts paper on Amgen’s Tavneos drug trial after FDA findings
--------------------------------------------------------------------
Source: The Jerusalem Post
Published: 2026-06-30 16:03 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Law & Courts, Drugs, Crime & Justice
--------------------------------------------------------------------
Snippet:
The New England Journal of Medicine on Monday retracted an article on a pivotal clinical trial that supported approval of Amgen’s rare-disease drug, citing concerns that patient outcome data were altered and that some researchers had been unblinded.
--------------------------------------------------------------------